Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit

被引:138
作者
Pene, Frederic [1 ,4 ]
Percheron, Stephanie [1 ]
Lemiale, Virginie [1 ]
Viallon, Vivian [2 ,4 ]
Claessens, Yann-Erick [3 ,4 ]
Marque, Sophie [1 ,4 ]
Charpentier, Julien [1 ]
Angus, Derek C. [1 ,4 ]
Cariou, Alain [1 ,4 ]
Chiche, Jean-Daniel [1 ,4 ]
Mira, Jean-Paul [1 ,4 ]
机构
[1] Cochin Hosp, AP HP, Med Intens Care Unit, Paris, France
[2] Cochin Hosp, AP HP, Dept Biostat, Paris, France
[3] Cochin Hosp, AP HP, Emergency Dept, Paris, France
[4] Univ Paris 05, Dept Cellular Biol, Cochin Inst, INSERM,CNRS,U567,UMR 8104, Paris, France
关键词
sepsis; septic shock; infection; immunodepression; cancer; hematological malignancy; intensive care unit;
D O I
10.1097/CCM.0B013E318165314B
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Septic shock is a severe, often terminal, complication of malignancy. For patients without malignancy, outcome from septic shock has improved with new advances in care. We wished to explore whether outcome from septic shock has similarly improved for cancer patients, with regard to implementation of recent adjuvant therapies. Design: An 8-yr retrospective observational study. Setting: A 24-bed medical intensive care unit in a university hospital. Patients. Patients were 238 consecutive cancer patients (solid tumors or hematologic malignancies) with septic shock admitted to the intensive care unit within two consecutive 4-yr periods: 1998-2001 and 2002-2005. Interventions: None. Measurements and Main Results. Septic shock occurred in 90 patients in 1998-2001 and 148 in 2002-2005. Management of septic shock between the two periods mostly differed by emergence of adjuvant therapies of sepsis (mainly low-dose glucocorticoids) and intensive insulin therapy and a more frequent use of renal replacement therapy in the recent period. Short-term survival rates were significantly higher during 2002-2005 compared with the previous 4-yr period: 28-day, intensive care unit, and hospital survival rates were 47.3% vs. 27.8% (p =.003), 41.2% vs. 26.7% (p =.02), and 36.5% vs. 21.1% (p =.01), respectively. After adjustment, intensive care unit admission between 2002 and 2005 was an independent favorable prognostic factor for short-term outcome. Improved survival was mainly observed in patients who did not require renal replacement therapy during their stay in the intensive care unit (hospital survival 65% in 2002-2005 vs. 21.4% in 1998-2001, p <.001). Conclusions: Improved outcome in critically ill cancer patients extended to the subgroup of patients with septic shock. This might be ascribed both to a better selection of patients and to improvements in the care and management, including new therapeutic strategies for sepsis.
引用
收藏
页码:690 / 696
页数:7
相关论文
共 34 条
  • [1] Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
    Alberti, C
    Brun-Buisson, C
    Burchardi, H
    Martin, C
    Goodman, S
    Artigas, A
    Sicignano, A
    Palazzo, M
    Moreno, R
    Boulmé, R
    Lepage, E
    Le Gall, JR
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (02) : 108 - 121
  • [2] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [3] Current epidemiology of septic shock - The CUB-Rea network
    Annane, D
    Aegerter, P
    Jars-Guincestre, MC
    Guidet, B
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (02) : 165 - 172
  • [4] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    Annane, D
    Sébille, V
    Charpentier, C
    Bollaert, PE
    François, B
    Korach, JM
    Capellier, G
    Cohen, Y
    Azoulay, E
    Troché, G
    Chaumet-Riffaut, P
    Bellissant, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871
  • [5] The prognosis of acute respiratory failure in critically ill cancer patients
    Azoulay, É
    Thiéry, G
    Chevret, S
    Moreau, D
    Darmon, M
    Bergeron, A
    Yang, K
    Meignin, V
    Ciroldi, M
    Le Gall, JR
    Tazi, A
    Schlemmer, B
    [J]. MEDICINE, 2004, 83 (06) : 360 - 370
  • [6] Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication
    Benoit, DD
    Vandewoude, KH
    Decruyenaere, JM
    Hoste, EA
    Colardyn, FA
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (01) : 104 - 112
  • [7] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [8] Prognostic factors for neutropenic patients in an intensive care unit: Respective roles of underlying malignancies and acute organ failures
    Blot, F
    Guiguet, M
    Nitenberg, G
    Leclercq, B
    Gachot, B
    Escudier, B
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) : 1031 - 1037
  • [9] Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.
    Brower, RG
    Matthay, MA
    Morris, A
    Schoenfeld, D
    Thompson, BT
    Wheeler, A
    Wiedemann, HP
    Arroliga, AC
    Fisher, CJ
    Komara, JJ
    Perez-Trepichio, P
    Parsons, PE
    Wolkin, R
    Welsh, C
    Fulkerson, WJ
    MacIntyre, N
    Mallatratt, L
    Sebastian, M
    McConnell, R
    Wilcox, C
    Govert, J
    Thompson, D
    Clemmer, T
    Davis, R
    Orme, J
    Weaver, L
    Grissom, C
    Eskelson, M
    Young, M
    Gooder, V
    McBride, K
    Lawton, C
    d'Hulst, J
    Peerless, JR
    Smith, C
    Brownlee, J
    Pluss, W
    Kallet, R
    Luce, JM
    Gottlieb, J
    Elmer, M
    Girod, A
    Park, P
    Daniel, B
    Gropper, M
    Abraham, E
    Piedalue, F
    Glodowski, J
    Lockrem, J
    McIntyre, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) : 1301 - 1308
  • [10] The epidemiology of sepsis in patients with malignancy
    Danai, Pajman A.
    Moss, Marc
    Mannino, David M.
    Martin, Greg S.
    [J]. CHEST, 2006, 129 (06) : 1432 - 1440